Key result
Perioperative intravenous lidocaine infusion significantly reduced postoperative pain intensity within 48 hours (MD -0.90) and improved quality of recovery on the first postoperative day compared to control in patients undergoing thyroid surgery.
Why the study?
Postoperative pain after thyroid surgery ranges from moderate to severe and can cause poor recovery, but the effects of lidocaine infusion on pain management and recovery were unexplored.
Does perioperative lidocaine infusion improve pain management and quality of recovery in patients undergoing thyroid surgery?
Meta-Analysis (n=761)
Does perioperative lidocaine infusion improve pain management and quality of recovery in patients undergoing thyroid surgery?
Mean Difference: -0.9 (95% CI -1.29–-0.5)
p-value: p=<0.00001
Perioperative lidocaine infusion alleviates postoperative pain and facilitates recovery on the first day after thyroid surgery without increasing adverse events.
IV lidocaine merits inclusion in multimodal regimens after thyroidectomy; extends efficacy data from other surgical populations.
Background Thyroid surgery is often considered minor, and the postoperative pain is usually ignored. However, according to previous researches, the pain after thyroid surgery ranged from moderate to severe. Poorly controlled pain may lead to a series of adverse events, including dissatisfaction of patients, bad recovery, and extended hospital stay. Intravenous infusion of lidocaine has been proven to be effective in relieving pain after cholecystectomy, spinal surgery, and colorectal surgery. This meta-analysis was designed to explore the effects of lidocaine infusion on pain management and quality of recovery after thyroid surgery. Methods We conducted a comprehensive search of the Cochrane Library, PUBMED, Web of Science, EMBASE, China National Knowledge Infrastructure (CNKI), Wanfang, VIP, and China Biomedical Literature Database (CBM) from inception to September 12, 2022. Based on our previously established inclusion and exclusion criteria, eligible studies were involved. The primary outcomes were postsurgical pain scores and quality of recovery. The secondary outcomes included opioids consumption, hemodynamics variables, time to awareness and extubation, and adverse events. All analyses were performed using the random effects model with RevMan 5.4 software. We also evaluated the evidence quality of results by GRADEprofiler 3.6. Results A sum of 11 RCTs with 761 patients were involved. Compared to the controlled group, lidocaine reduced pain scores at 2h, 4h, 8h, and 12h after surgery, but not at 24h and 48h. Besides, lidocaine also facilitated recovery (mean difference [MD] = 7, 95% CI [4.78–9.25], P = 0.40, I2 = 0%), reduced opioids consumption during surgery (MD=-5.61, 95% CI [-7.90, -3.31], P = 0.97, I2 = 0%), and lowered the incidence of cough during extubation (RR = 0.41, 95% CI [0.30, 0.56], P = 0.34, I2 = 10%). No lidocaine-related adverse events was found in our meta-analysis. Conclusions Perioperative infusions of lidocaine could alleviate postoperative pain and facilitate recovery on the first day after surgery, without causing adverse events. Considering the high heterogeneity and relatively low quality of evidence among most of the results, further validation is reasonable.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) conducted a meta-analysis in thyroid surgery (n=761). Perioperative lidocaine infusion vs. placebo or untreated was evaluated on postsurgical pain scores within 48h after surgery (MD -0.90, 95% CI -1.29 to -0.50, p=<0.00001). Perioperative intravenous lidocaine infusion significantly reduced postoperative pain intensity within 48 hours (MD -0.90) and improved quality of recovery on the first postoperative day compared to control in patients undergoing thyroid surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: